Vitalhub Corp. (TSE:VHI - Get Free Report) has earned a consensus recommendation of "Buy" from the seven ratings firms that are presently covering the company, Marketbeat reports. Six analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is C$13.25.
VHI has been the subject of a number of recent research reports. Scotiabank lifted their price objective on Vitalhub from C$14.00 to C$14.50 and gave the stock an "outperform" rating in a research report on Friday, June 20th. National Bankshares set a C$14.00 price objective on Vitalhub and gave the stock an "outperform" rating in a research report on Tuesday, June 10th. Raymond James Financial raised their price target on Vitalhub from C$13.50 to C$14.00 and gave the stock an "outperform" rating in a research note on Friday, June 20th. Finally, National Bank Financial raised Vitalhub to a "strong-buy" rating in a research note on Monday, June 9th.
View Our Latest Research Report on Vitalhub
Vitalhub Stock Down 1.7%
Shares of TSE VHI traded down C$0.23 during mid-day trading on Wednesday, hitting C$13.53. 241,434 shares of the company were exchanged, compared to its average volume of 131,067. Vitalhub has a 1-year low of C$7.48 and a 1-year high of C$14.34. The firm has a market cap of C$731.87 million, a price-to-earnings ratio of 220.06, a price-to-earnings-growth ratio of 1.18 and a beta of 1.26. The stock has a 50 day simple moving average of C$11.43 and a 200-day simple moving average of C$10.78.
Insider Activity
In related news, Director Francis Nelson Shen bought 25,000 shares of the stock in a transaction that occurred on Friday, May 16th. The shares were acquired at an average price of C$10.23 per share, with a total value of C$255,750.00. 18.57% of the stock is owned by corporate insiders.
About Vitalhub
(
Get Free ReportVitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Featured Stories

Before you consider Vitalhub, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.
While Vitalhub currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.